Evolving into a Total Medical Aesthetics Company Integrating Manufacturing,
Distribution, and Cosmetics Based on Patented Medical Device Technology
South Korean medical and bio company Nexvel Biotech is drawing industry attention as it officially begins expanding into global markets following its participation in BEAUTYISTANBUL 2026.
Built upon patented medical device technologies, the company has established a business structure that directly manages the entire process from manufacturing to export and distribution.
More recently, Nexvel Biotech has successfully launched a technology-based cosmetic brand, further strengthening its competitiveness in the medical aesthetics sector.
Leveraging its accumulated expertise in medical devices and aesthetic medicine, Nexvel Biotech has developed an integrated business system that organically connects in-house research and development (R&D), manufacturing, and global distribution networks. Industry analysts note that the company differentiates itself by going beyond conventional OEM and ODM production, directly overseeing product planning, technology development, manufacturing, quality control, and overseas distribution.
Industry experts point out that the global medical aesthetics market is increasingly shifting away from simple price competition toward a structure that prioritizes technological reliability, product safety, and brand competitiveness. In response to this trend, Nexvel Biotech has strengthened its global market competitiveness by enhancing product quality through its proprietary patented technologies.
Through its participation in BEAUTYISTANBUL 2026, Nexvel Biotech actively introduced its medical aesthetics technologies and brand competitiveness to buyers across Europe, the Middle East, and Asia.
During the exhibition, the company’s Aesthetic Medicines portfolio—including skin boosters and dermal fillers—received strong interest from overseas medical professionals and buyers, with positive evaluations focusing on product stability and differentiated formulation technologies.
In particular, the company’s medical device-based technologies are now being applied to its recently launched cosmetic brand, generating positive market responses. Industry observers believe that this medically driven functional cosmetics approach aligns well with growing global consumer demand for products that combine efficacy, safety, and professional expertise.
The global beauty market has recently seen rapid growth in the “cosmeceutical” sector, where consumers increasingly seek both skin improvement benefits and medical-grade reliability, further increasing the market influence of companies with medical technology expertise.
Keeping pace with these trends, Nexvel Biotech is expanding the R&D capabilities and quality management systems established in the medical device sector into the cosmetics field. Industry insiders note that global markets are increasingly placing greater trust in companies that directly operate their own manufacturing infrastructure and quality control systems. They also emphasize that medical technology-based companies entering the cosmetics industry can gain strong advantages in both product reliability and premium brand positioning.
At the same time, Nexvel Biotech is accelerating the expansion of its global distribution network.
Beginning with the Istanbul exhibition, the company plans to continue participating in major international exhibitions across Europe, the Middle East, and Asia to strengthen overseas partnerships and export channels.
Active consultations with buyers and distributors from various countries are already underway, and discussions regarding exclusive distribution agreements and long-term supply partnerships are reportedly progressing in several regions.
A representative from Nexvel Biotech stated, “Based on our patented technologies, in-house production infrastructure, and global distribution capabilities, we plan to further strengthen our competitiveness in the medical aesthetics market.
We aim to build sustainable growth in global markets by expanding not only our medical device business but also our technology-driven cosmetics sector.”
Meanwhile, the global medical aesthetics and cosmeceutical markets continue to experience steady growth driven by increasing demand for skin health and anti-aging solutions.
Industry experts expect Korean companies that successfully secure technological expertise, manufacturing competitiveness, and global distribution capabilities simultaneously to stand out even more prominently in overseas markets in the future.
